SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2077)1/4/2008 10:51:02 AM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
PPDI Is trying to test its Nov30 H of $43.14 The stock has been up 5.12% today, but is up only 3.4% at present.<g>

bigcharts.marketwatch.com

On Oct 23 it announced the opening of offices in Sydney, Australia; Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru; reflecting continued expansion of its Phase II-IV services in key therapeutic areas, & on Dec12 it announced that Phillip Mathew, a native of India,will lead its development operations and expansion there & will open a second office in Mumbai.

PPDI has offices in 30 countries and more than 10,000 professionals worldwide.

The stock trades around 5xBV; the short ratio came down 11% in the last month, but is still around 5x its ADV.In Nov it increased a little its dividend. (It is around 1% <g>)

On a close above $44 the stock will be able to make an all time H.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (2077)1/23/2008 9:17:15 AM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
HGSI will open with a DG, it is trading down 29% in PM.<g>

bigcharts.marketwatch.com

It said that it will lower the dosage of Albuferon, its hepatitis C drug, in response to serious lung-related safety concerns.

HGSI is down to $7.70 in PM

Bernard